Showing results (511-520 of 2,733) with videos related to
Sort By:
Pageof 274
Pharmacogenomics|May 12, 2016
Pharmacogenetic aspects of the treatment of Type 2 diabetes with the incretin effect enhancersIvan Tkáč, Ivana GotthardováPharmacogenomics|May 17, 2016
Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemiaElixabet Lopez-Lopez, Angela Gutierrez-Camino, Itziar Astigarraga, et al.Pharmacogenomics|May 17, 2016
Evaluation of clinical implementation of prospective DPYD genotyping in 5-fluorouracil- or capecitabine-treated patientsCarin Atc Lunenburg, Maurice C van Staveren, Hans Gelderblom, et al.Pharmacogenomics|June 9, 2016
MTHFR gene polymorphisms and methotrexate toxicity in adult patients with hematological malignancies: a meta-analysisMing Zhao, Liang Liang, Liwei Ji, et al.Pharmacogenomics|June 2, 2016
Requirements for comprehensive pharmacogenetic genotyping platformsVolker M Lauschke, Magnus Ingelman-SundbergPharmacogenomics|June 2, 2016
Cost-effectiveness of screening for DPYD polymorphisms to prevent neutropenia in cancer patients treated with fluoropyrimidinesLucía Cortejoso, Xandra García-González, María I García, et al.Pharmacogenomics|December 7, 2017
Genome-wide scan identifies candidate loci related to remifentanil requirements during laparoscopic-assisted colectomyDaisuke Nishizawa, Tsutomu Mieda, Miki Tsujita, et al.Pharmacogenomics|November 28, 2017
miR-509-3p promotes cisplatin-induced apoptosis in ovarian cancer cells through the regulation of anti-apoptotic genesWei Chen, Jingjie Du, Xiaodi Li, et al.Pharmacogenomics|November 28, 2017
Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatinClaudia Lanvers-Kaminsky, Giuliano CiarimboliPharmacogenomics|November 3, 2017
Rethinking ovarian cancer genomics: where genome-wide association studies stand?Ricardo Pinto, Joana Assis, Augusto Nogueira, et al.Pageof 274